Answers are grounded in this paper and cite their sources.
OBJECTIVE: To explore efficacy and cardiopulmonary effects of medetomidine and butorphanol, with or without vatinoxan, in healthy puppies. STUDY DESIGN: Randomised, blinded clinical trial. ANIMALS: A group of healthy client-owned puppies aged between 42 and 51 days scheduled for elective brainstem auditory-evoked response (BAER) testing. METHODS: . Linear mixed models were created to investigate the effects of time and treatment group on PR and MAP. RESULTS: < 95%), observed in 18/32 puppies when breathing room air. Hypoxaemia resolved with supplemental oxygen. Recoveries from sedation were uneventful. CONCLUSIONS AND CLINICAL RELEVANCE: Medetomidine-butorphanol is an effective combination for sedation of puppies. Adding vatinoxan maintains higher PR. Provision of supplemental oxygen during sedation is recommended.
No takes yet. Share an insight, caveat, or question.
Pekkola et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: